Abstract
AbstractIntroductionBloodstream infections are a commonly encountered clinical syndrome of public health concern with variable epidemiology. The characteristic of resistance to multiple antibiotics by their etiologic agents has limited the options for empirical sepsis case management. This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-Central Uganda.Materials and methodsThis retrospective study involved analysis of all non-duplicate blood culture reports from 2019 to 2021. The frequency and percentage of significant pathogenic organisms and contaminants were calculated. Positivity distribution including infection sources was determined. World Health Organization Network (WHONET) 2022 desktop software was used for antimicrobial susceptibility data analysis.ResultsThe 1364 participants had a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated byStaphylococcus aureus39(34.2%). Gram-negatives mainly included unspecifiedColiforms12(10.5%), andE. coli10(8.8%). Polymicrobial growth existed in 4(0.3%) cases.S. aureuswas mainly resistant to Penicillin G (100%), Cefoxitin (60%), and Erythromycin (52.2%). BothEscherichia coliand unspecifiedcoliformsshowed high resistance to Ampicillin (87.5%) and third-generation Cephalosporins (100%). The least resistance was to Chloramphenicol and Carbapenems.ConclusionBSIs are mainly due to Gram-positive bacteria. Suspected sepsis cases byS. aureusin this region can be empirically managed using Gentamicin. Microbiology services should be routinely utilized to guide antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.
Publisher
Cold Spring Harbor Laboratory
Reference33 articles.
1. Bloodstream infections in critically ill patients: an expert statement;Intensive Care Medicine,2020
2. Santoro A , Franceschini E , Meschiari M , Menozzi M , Zona S , Venturelli C , et al. Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria. Open Forum Infectious Diseases. 2020;7(11).
3. Duan N , Sun L , Huang C , Li H , Cheng B . Microbial Distribution and Antibiotic Susceptibility of Bloodstream Infections in Different Intensive Care Units. Front Microbiol. 2021;12:792282.
4. Hussain MS , Basher H , Lone MS , Wani K. Bloodstream Infections in Pediatric Population in a Tertiary Care Hospital. 2019.
5. NHSN. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection) 2023 [updated 2023, January. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf